longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Larimar Therapeutics

LRMR

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Weekly Recap | MOAT.US -0.89%, lighter-volume pullback

    Weekly Review·Sep 19 at 07:40 AM
    MOAT-0.29%
  • Weekly Recap | ARKG.US +13.35%, AI healthcare leads genomics theme

    Weekly Review·Sep 19 at 07:15 AM
    ARKG+2.85%
  • Weekly Recap | Twist Bioscience +31.26%, signs deal with Lilly TuneLab

    Weekly Review·Sep 19 at 06:54 AM
    TWST+10.99%
  • Weekly Recap | RXRX.US +19.69%, most brokers rate it buy

    Weekly Review·Sep 19 at 06:40 AM
    RXRX+0.27%
  • Weekly Recap | Novavax +7.32%, outperforming the S&P 500

    Weekly Review·Sep 19 at 06:28 AM
    NVAX+0.52%
  • Weekly Recap | Larimar Therapeutics +2.35%, most brokers rate it buy

    Weekly Review·Sep 12 at 06:12 AM
    LRMR-7.76%
  • The S&P Pharmaceutical Index closed up about 5.2%, and the Biotechnology Index rose 2.6%

    Wallstreetcn·Oct 1, 2025 at 08:26 PM
    NVAX+0.52%APLT0.00%
  • The Nasdaq Biotechnology Index rose 2.2%, reaching an intraday high since 2021

    Wallstreetcn·Oct 1, 2025 at 02:12 PM
    REGN+0.29%ARCT+7.03%